vs

Side-by-side financial comparison of Elevance Health (ELV) and JPMorgan Chase (JPM). Click either name above to swap in a different company.

Elevance Health is the larger business by last-quarter revenue ($49.7B vs $45.8B, roughly 1.1× JPMorgan Chase). JPMorgan Chase runs the higher net margin — 28.4% vs 1.1%, a 27.3% gap on every dollar of revenue.

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon.

JPMorgan Chase & Co. is an American multinational banking institution headquartered in New York City and incorporated in Delaware. It is the largest bank in the United States, and the world's largest bank by market capitalization as of 2025. As the largest of the Big Four banks in America, the firm is considered systemically important by the Financial Stability Board.

ELV vs JPM — Head-to-Head

Bigger by revenue
ELV
ELV
1.1× larger
ELV
$49.7B
$45.8B
JPM
Higher net margin
JPM
JPM
27.3% more per $
JPM
28.4%
1.1%
ELV

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ELV
ELV
JPM
JPM
Revenue
$49.7B
$45.8B
Net Profit
$547.0M
$13.0B
Gross Margin
88.9%
Operating Margin
0.6%
37.5%
Net Margin
1.1%
28.4%
Revenue YoY
1.8%
Net Profit YoY
-74.9%
EPS (diluted)
$2.56
$4.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ELV
ELV
JPM
JPM
Q1 26
$49.7B
Q4 25
$49.7B
$45.8B
Q3 25
$50.7B
$46.4B
Q2 25
$49.8B
$44.9B
Q1 25
$48.9B
$45.3B
Q4 24
$45.4B
Q3 24
$45.1B
$42.7B
Q2 24
$43.9B
$50.2B
Net Profit
ELV
ELV
JPM
JPM
Q1 26
$547.0M
Q4 25
$547.0M
$13.0B
Q3 25
$1.2B
$14.4B
Q2 25
$1.7B
$15.0B
Q1 25
$2.2B
$14.6B
Q4 24
$418.0M
Q3 24
$1.0B
$12.9B
Q2 24
$2.3B
$18.1B
Gross Margin
ELV
ELV
JPM
JPM
Q1 26
88.9%
Q4 25
88.9%
Q3 25
89.4%
Q2 25
89.4%
Q1 25
89.8%
Q4 24
86.8%
Q3 24
88.7%
Q2 24
89.0%
Operating Margin
ELV
ELV
JPM
JPM
Q1 26
0.6%
Q4 25
0.6%
37.5%
Q3 25
2.6%
40.4%
Q2 25
4.9%
40.7%
Q1 25
6.5%
40.6%
Q4 24
1.5%
Q3 24
3.1%
39.8%
Q2 24
6.3%
46.7%
Net Margin
ELV
ELV
JPM
JPM
Q1 26
1.1%
Q4 25
1.1%
28.4%
Q3 25
2.3%
31.0%
Q2 25
3.5%
33.4%
Q1 25
4.5%
32.3%
Q4 24
0.9%
Q3 24
2.3%
30.2%
Q2 24
5.2%
36.2%
EPS (diluted)
ELV
ELV
JPM
JPM
Q1 26
$2.56
Q4 25
$2.56
$4.64
Q3 25
$5.32
$5.07
Q2 25
$7.72
$5.24
Q1 25
$9.61
$5.07
Q4 24
$1.88
Q3 24
$4.36
$4.37
Q2 24
$9.85
$6.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ELV
ELV
JPM
JPM
Cash + ST InvestmentsLiquidity on hand
$9.5B
Total DebtLower is stronger
$31.9B
Stockholders' EquityBook value
$43.9B
$362.4B
Total Assets
$121.5B
$4424.9B
Debt / EquityLower = less leverage
0.73×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ELV
ELV
JPM
JPM
Q1 26
$9.5B
Q4 25
$9.5B
Q3 25
$8.7B
Q2 25
$8.6B
Q1 25
$7.5B
Q4 24
$8.3B
Q3 24
$7.9B
Q2 24
$6.5B
Total Debt
ELV
ELV
JPM
JPM
Q1 26
$31.9B
Q4 25
$31.9B
Q3 25
Q2 25
Q1 25
Q4 24
$30.9B
Q3 24
Q2 24
Stockholders' Equity
ELV
ELV
JPM
JPM
Q1 26
$43.9B
Q4 25
$43.9B
$362.4B
Q3 25
$44.0B
$360.2B
Q2 25
$43.7B
$356.9B
Q1 25
$42.5B
$351.4B
Q4 24
$41.3B
Q3 24
$43.8B
$345.8B
Q2 24
$42.2B
$340.6B
Total Assets
ELV
ELV
JPM
JPM
Q1 26
$121.5B
Q4 25
$121.5B
$4424.9B
Q3 25
$122.7B
$4560.2B
Q2 25
$121.9B
$4552.5B
Q1 25
$119.7B
$4357.9B
Q4 24
$116.9B
Q3 24
$116.5B
$4210.0B
Q2 24
$113.0B
$4143.0B
Debt / Equity
ELV
ELV
JPM
JPM
Q1 26
0.73×
Q4 25
0.73×
Q3 25
Q2 25
Q1 25
Q4 24
0.75×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ELV
ELV
JPM
JPM
Operating Cash FlowLast quarter
$119.7B
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
9.19×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ELV
ELV
JPM
JPM
Q1 26
Q4 25
$84.0M
$119.7B
Q3 25
$1.1B
$-45.2B
Q2 25
$2.1B
$29.5B
Q1 25
$1.0B
$-251.8B
Q4 24
$706.0M
Q3 24
$2.7B
Q2 24
$447.0M
Free Cash Flow
ELV
ELV
JPM
JPM
Q1 26
Q4 25
$-209.0M
Q3 25
$775.0M
Q2 25
$1.8B
Q1 25
$821.0M
Q4 24
$384.0M
Q3 24
$2.3B
Q2 24
$124.0M
FCF Margin
ELV
ELV
JPM
JPM
Q1 26
Q4 25
-0.4%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
1.7%
Q4 24
0.8%
Q3 24
5.2%
Q2 24
0.3%
Capex Intensity
ELV
ELV
JPM
JPM
Q1 26
Q4 25
0.6%
Q3 25
0.7%
Q2 25
0.5%
Q1 25
0.4%
Q4 24
0.7%
Q3 24
0.7%
Q2 24
0.7%
Cash Conversion
ELV
ELV
JPM
JPM
Q1 26
Q4 25
0.15×
9.19×
Q3 25
0.95×
-3.14×
Q2 25
1.18×
1.97×
Q1 25
0.47×
-17.20×
Q4 24
1.69×
Q3 24
2.63×
Q2 24
0.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ELV
ELV

Segment breakdown not available.

JPM
JPM

Other$19.7B43%
Commercial And Investment Bank$19.4B42%
Assetand Wealth Management Segment$6.5B14%
Consumer Community Banking$188.0M0%

Related Comparisons